MI
MoonLake Immunotherapeutics
🇺🇸XNAS.MLTXUnited StatesHealthcare
$12.46USDup +0.25 (+2.05%)ClosedEnd of day12:15 AM
Price$12.46+0.25 (+2.05%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- KY61559X1045
- CUSIP
- Not reported
Company
- Employees
- 130
- Headquarters
- Zug, United States
- Website
- https://www.moonlaketx.com
- CEO
- Dr. Jorge Santos da Silva Ph.D.
Market
- Shares outstanding
- 85.1M
- Market cap
- $1.06B
Key dates
- Next earnings
- Nov 4, 2026
Highlights
- Market cap
- $1.04B
- EPS LTM
- -$3.10calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -4.02calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$263.67M-49.68%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$225.18M-35.03%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.